| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/10/2013 | CN103193720A Preparation method of pirimicarb |
| 07/10/2013 | CN103193719A Preparation method of 4-[(4-Hydroxy-2-pyrimidinyl) amino] benzonitrile |
| 07/10/2013 | CN103193718A A 4-substituted derivative of 5-bromopyrimidine and a preparation method thereof |
| 07/10/2013 | CN103193717A Phenylene bipyrimidinyl compound, as well as synthesis method and application thereof |
| 07/10/2013 | CN103193716A Method for preparing 3,4-dihydropyrimidine-2 (1H)-ketone derivative via catalysis of acidic ionic liquid |
| 07/10/2013 | CN103193715A Preparation method of 5,6-dihydropyrimidone derivative |
| 07/10/2013 | CN103193702A Functionalization method for nitrogenous heterocyclic compound |
| 07/10/2013 | CN103193691A Sulfonamide compound and medicinal compositions thereof, and preparation methods and applications thereof |
| 07/10/2013 | CN101627019B Bicyclic pyrimidinones and uses thereof |
| 07/10/2013 | CN101463014B Diaryl benzo pyridine derivative, and its pharmaceutical composition and use thereof |
| 07/10/2013 | CN101253158B Process for synthesis of aryloxy diaminopyrimidines |
| 07/09/2013 | US8481732 Substituted heterocyclic compounds |
| 07/09/2013 | US8481730 Method of synthesis of Bosentan, its polymorphic forms and its salts |
| 07/09/2013 | US8481729 Processes for the preparation of paliperidone |
| 07/09/2013 | US8481552 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea |
| 07/09/2013 | US8481551 Gyrase and topoisomerase IV inhibitors |
| 07/09/2013 | US8481550 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 07/09/2013 | US8481531 Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use |
| 07/09/2013 | US8481459 Chemical inhibitors of ethylene biosynthesis |
| 07/09/2013 | CA2520323C Tie-2 modulators and methods of use |
| 07/09/2013 | CA2516407C Heteroarylcarbamoylbenzene derivatives |
| 07/04/2013 | WO2013102111A1 2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine- carbaldehydes, and methods of formation and use |
| 07/04/2013 | WO2013098577A1 Pharmaceutical compositions of bosentan |
| 07/04/2013 | WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| 07/04/2013 | US20130172558 Naproxen-based chiral compounds and liquid crystal display applications |
| 07/04/2013 | US20130172557 2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine- carbaldehydes, and methods of formation and use |
| 07/04/2013 | US20130172350 Pyrimidine compounds and their uses |
| 07/04/2013 | US20130172334 Trpv1 antagonists |
| 07/04/2013 | DE112010005848T5 Amidverbindungen Amide compounds |
| 07/03/2013 | EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
| 07/03/2013 | EP2608666A1 Phenylamidines having a high fungicidal activity and use thereof |
| 07/03/2013 | CN103189527A Non metal tanning |
| 07/03/2013 | CN103183644A Uracil zinc salt and application thereof as heat stabilizer for PVC |
| 07/03/2013 | CN103183643A Rilpivirine intermediate and preparation method and application thereof |
| 07/03/2013 | CN103183642A Intermediate used for synthesizing rilpivirine and preparation method and application in rilpivirine synthesis thereof |
| 07/03/2013 | CN103183641A Preparation method of rilpivirine intermediate |
| 07/03/2013 | CN103181926A Broad-spectrum antitumor drug and application thereof |
| 07/03/2013 | CN102146060B Method for preparing gefitinib and intermediate thereof |
| 07/03/2013 | CN101678007B Gonadotropin-releasing hormone receptor antagonists and its pharmaceutical application |
| 07/02/2013 | US8476435 Method for producing fluorine-containing polyether carboxylic acid amide |
| 07/02/2013 | US8476432 Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof |
| 07/02/2013 | US8476298 c-Met modulators and method of use |
| 07/02/2013 | US8476288 Salts 756 |
| 07/02/2013 | US8476287 3-hydroxy-5-arylisothiazole derivative |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476281 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea |
| 07/02/2013 | US8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor |
| 07/02/2013 | US8475888 Five-ring liquid crystal compound having a nitrogen-containing heterocyclic ring, liquid crystal composition and liquid crystal display device |
| 07/02/2013 | CA2745829C Chemical process |
| 07/02/2013 | CA2637573C 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives |
| 06/27/2013 | WO2013096226A1 Trpv1 antagonists |
| 06/27/2013 | WO2013096194A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/27/2013 | WO2013092900A1 Synthesis of triazolopyrimidine compounds |
| 06/27/2013 | WO2013092460A1 Cyclic bisoxime microbicides |
| 06/27/2013 | WO2013091507A1 Heterocycle amido alkyloxy substituted quinazoline derivative and use thereof |
| 06/27/2013 | US20130165462 Heteroaryl compounds and uses thereof |
| 06/27/2013 | US20130165458 Quinazoline compounds as kinase inhibitors |
| 06/27/2013 | US20130165431 Inhibitors of syk and jak protein kinases |
| 06/27/2013 | US20130164847 Use of a protein tyrosine kinase inhibitor for inducing the differentiation of mesenchymal stem cells into cardiogenic cells |
| 06/27/2013 | CA2856448A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/26/2013 | WO2013079493A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/26/2013 | EP2607355A1 Synthesis of triazolopyrimidine compounds |
| 06/26/2013 | CN103172577A 4-aminoquinoline and 4-aminoquinoline compound and applications of compound |
| 06/26/2013 | CN103172576A Malic acid addition salts of Gefitinib, preparation and application |
| 06/26/2013 | CN103172575A Preparation method of one-class 1,3-dipole quinazoline compound |
| 06/26/2013 | CN103172574A Novel synthesis process of 2-substituted-4,6-dialkoxy pyrimidine |
| 06/26/2013 | CN103172573A Particulates of crth2 antagonist |
| 06/26/2013 | CN103172572A Particulates of crth2 antagonist |
| 06/26/2013 | CN102250019B (Thio) barbituric acid compound and application thereof |
| 06/26/2013 | CN101643450B Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone |
| 06/26/2013 | CA2852609A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/25/2013 | US8471013 Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives |
| 06/25/2013 | US8471012 Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B |
| 06/25/2013 | US8471011 Preparation of acid addition salts of amine bases by solid phase—gas phase reactions |
| 06/25/2013 | US8470861 Mitochondria-targeted antioxidant prodrugs and methods of use |
| 06/25/2013 | US8470839 N1-acyl-5-fluoropyrimidinone derivatives |
| 06/25/2013 | US8470838 Quinazolinones useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity; N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide monomethanesulfonate; treating breast cancer |
| 06/25/2013 | US8470835 Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase |
| 06/25/2013 | US8470834 AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 06/25/2013 | US8470820 Nitrogen-containing heteroaryl derivatives |
| 06/20/2013 | WO2013090454A2 Novel glp-1 receptor modulators |
| 06/20/2013 | WO2013087794A1 Polymorph of rilpivirine hydrochloride and its use as antiviral |
| 06/20/2013 | WO2013056003A3 Catechol diethers as potent anti-hiv agents |
| 06/20/2013 | WO2013046222A3 A process for the preparation of amorphous rosuvastatin calcium |
| 06/20/2013 | US20130158263 Intermediates for the preparation of hmg coa reductase inhibitors and processes for the preparation thereof |
| 06/20/2013 | US20130158260 Aminodihydrothiazine derivatives |
| 06/20/2013 | US20130158259 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158054 Polymorphs of 3-(e)-2--3-methoxyacrylate |
| 06/20/2013 | US20130158053 Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide |
| 06/20/2013 | US20130158032 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130158005 Pyrimidine derivatives as fak inhibitors |
| 06/20/2013 | US20130157999 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130157971 2'-fluoronucleosides |
| 06/20/2013 | US20130157851 Phenylamidines having a high fungicidal activity and use thereof |
| 06/20/2013 | US20130157190 Charge control agent and toner using the same |
| 06/20/2013 | US20130156700 Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2 |
| 06/20/2013 | CA2857197A1 Novel glp-1 receptor modulators |
| 06/19/2013 | EP2604593A1 Polymorph of Rilpivirine hydrochloride and its use as antiviral |
| 06/19/2013 | EP2603497A1 A novel process for preparation of bosentan |